LataMed AI Corp. to Attend MEDICA 2026 in Germany as Part of Healthcare Technology Strategy
LataMed AI Corp. will attend MEDICA 2026 in Dusseldorf to evaluate technologies and build relationships for its digital healthcare platform in Latin America.
LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure and healthcare analytics for emerging markets, announced that its representatives plan to attend MEDICA 2026 in Dusseldorf, Germany, one of the world's largest international healthcare and medical technology trade fairs.
The company stated that attendance at MEDICA is intended to support its ongoing evaluation of healthcare technologies, strategic industry relationships, vendor solutions, digital infrastructure initiatives, and broader commercialization opportunities associated with its developing healthcare technology ecosystem. LataMed plans to engage with healthcare technology providers, telehealth vendors, pharmaceutical infrastructure participants, medical software developers, AI-focused healthcare companies, and other industry stakeholders operating throughout Europe, Latin America, and additional international markets.
Management believes participation in international healthcare industry events may provide opportunities to evaluate emerging technologies, support industry relationship development, and advance the company's long-term digital healthcare infrastructure strategy across Latin America and other developing markets. Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "Healthcare systems around the world are rapidly moving toward technology-driven and AI-enabled infrastructure models. Our attendance at MEDICA reflects our commitment to engaging with industry participants, evaluating emerging technologies, and continuing to build a scalable healthcare platform designed to support long-term digital healthcare modernization initiatives throughout Latin America."
The company remains in the development and commercialization stage with respect to certain aspects of its healthcare technology platform and business operations. It cautioned that attendance at industry conferences and trade fairs does not guarantee strategic relationships, commercial agreements, financing arrangements, technology integrations, revenue generation, or future operational success.
LataMed continues to advance telehealth deployment initiatives, healthcare analytics integration, operational scalability planning, strategic relationship development, and broader commercialization efforts associated with its long-term digital healthcare ecosystem strategy throughout Latin America. The company is positioning itself to participate in the ongoing modernization and digital transformation of healthcare delivery systems across emerging markets through telehealth infrastructure development, artificial intelligence-driven healthcare technologies, regulatory progression initiatives, strategic relationships, and operational expansion efforts.
For more information, visit https://latamed.ai, follow the company's official Instagram page at https://www.instagram.com/latamedai, or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.